4 ms·
The ScienceInsider article[1] they cite does not mention intellectual property a single time. To me, this reads like baseless speculation from CBC, when there
by cowsandmilk 12y ago
The ScienceInsider article[1] they cite does not mention intellectual property a single time. To me, this reads like baseless speculation from CBC, when there are a litany of possible reasons for the delays listed by both sides in the ScienceInsider article. Things like protocol design for how the clinical trial should be performed are not "IP" spats, but science and statistics spats. What endpoints do you use to declare a vaccine is effective? How should patients be monitored for side effects? etc.
[1] http://news.sciencemag.org/africa/2014/09/ebola-vaccine-tests-needlessly-delayed-researchers-claim http://news.sciencemag.org/africa/2014/09/ebola-vaccine-test...